M. Kraml

1.4k total citations
66 papers, 1.2k citations indexed

About

M. Kraml is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, M. Kraml has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Pharmacology and 11 papers in Surgery. Recurrent topics in M. Kraml's work include Analytical Methods in Pharmaceuticals (11 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Cholesterol and Lipid Metabolism (10 papers). M. Kraml is often cited by papers focused on Analytical Methods in Pharmaceuticals (11 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Cholesterol and Lipid Metabolism (10 papers). M. Kraml collaborates with scholars based in United States, Canada and Germany. M. Kraml's co-authors include D. Dvornik, J.-E. Dubuc, David Hicks, Jehan F. Bagli, Roger Gaudry, Morris L. Givner, Mitchell N. Cayen, Leslie G. Humber, E. Greselin and Eckhardt S. Ferdinandi and has published in prestigious journals such as Nature, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

M. Kraml

65 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Kraml United States	18	396	240	201	171	115	66	1.2k
M. Galli Kienle Italy	23	766 1.9×	325 1.4×	125 0.6×	80 0.5×	125 1.1×	103	1.6k
Bhupendra S. Kaphalia United States	24	497 1.3×	311 1.3×	106 0.5×	108 0.6×	132 1.1×	94	1.8k
Walter D. Wosilait United States	20	809 2.0×	135 0.6×	71 0.4×	146 0.9×	131 1.1×	66	1.7k
K Krisch Germany	25	841 2.1×	169 0.7×	489 2.4×	195 1.1×	152 1.3×	106	1.8k
Ruth E. Billings United States	22	436 1.1×	69 0.3×	140 0.7×	338 2.0×	73 0.6×	51	1.4k
Edward J. Van Loon United States	16	260 0.7×	180 0.8×	49 0.2×	198 1.2×	73 0.6×	40	1.0k
A. Crastes de Paulet France	24	674 1.7×	432 1.8×	148 0.7×	69 0.4×	212 1.8×	103	1.7k
Claude R. Gunter United States	6	582 1.5×	138 0.6×	75 0.4×	71 0.4×	188 1.6×	8	1.2k
Jeremy D. Hribar United States	13	319 0.8×	65 0.3×	230 1.1×	156 0.9×	194 1.7×	24	975
George E. Phillips United States	14	268 0.7×	83 0.3×	64 0.3×	133 0.8×	120 1.0×	34	921

Countries citing papers authored by M. Kraml

Since Specialization

Citations

This map shows the geographic impact of M. Kraml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kraml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kraml more than expected).

Fields of papers citing papers by M. Kraml

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kraml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kraml. The network helps show where M. Kraml may publish in the future.

Co-authorship network of co-authors of M. Kraml

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kraml. A scholar is included among the top collaborators of M. Kraml based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kraml. M. Kraml is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kraml, M., et al.. (2017). Cell-free protein synthesis from non-growing, stressed Escherichia coli. Scientific Reports. 7(1). 16524–16524. 32 indexed citations

Kraml, M., et al.. (2016). Site-Specific Cleavage of Ribosomal RNA in Escherichia coli-Based Cell-Free Protein Synthesis Systems. PLoS ONE. 11(12). e0168764–e0168764. 20 indexed citations

Fruncillo, Richard J., Steven Troy, Vernon D. Parker, et al.. (1996). Pharmacokinetics of the aldose reductase inhibitor tolrestat: Studies in healthy young and elderly male and female subjects and in subjects with diabetes. Clinical Pharmacology & Therapeutics. 59(6). 603–612. 4 indexed citations

Hicks, David, et al.. (1994). A High-Performance Liquid Chromatographic Method for the Simultaneous Determination of Venlafaxine and O-Desmethylvenlafaxine in Biological Fluids. Therapeutic Drug Monitoring. 16(1). 100–107. 70 indexed citations

Blakeley, Stephen D., et al.. (1994). Isolation of a Full-Length cDNA Encoding Cytosolic Enolase from Ricinus communis. PLANT PHYSIOLOGY. 105(1). 455–456. 8 indexed citations

Dvornik, D., Jane Millen, David Hicks, & M. Kraml. (1994). Tolrestat pharmacokinetics in rat peripheral nerve. Journal of Diabetes and its Complications. 8(1). 18–26. 11 indexed citations

Troy, Steven, David Hicks, M. Kraml, Kenneth A. Conrad, & Soong T. Chiang. (1992). The effect of renal disease on tolrestat pharmacokinetics. Clinical Pharmacology & Therapeutics. 51(3). 271–277. 3 indexed citations

Cayen, Mitchell N., Eckhardt S. Ferdinandi, David Hicks, et al.. (1990). Pharmacokinetics and disposition of the lipid-lowering drug acifran in normal subjects and in patients with renal failure. Clinical Pharmacology & Therapeutics. 47(1). 50–56. 3 indexed citations

Hicks, David, et al.. (1990). Metabolic disposition and pharmacokinetics of pelrinone, a new cardiotonic drug, in laboratory animals and man. European Journal of Drug Metabolism and Pharmacokinetics. 15(1). 37–48. 8 indexed citations

10.

Scatina, JoAnn, David Hicks, M. Kraml, & Mitchell N. Cayen. (1989). Disposition of a new tetrahydrocarbazole analgesic drug in laboratory animals and man. Xenobiotica. 19(9). 991–1002. 15 indexed citations

11.

Kraml, M., David Hicks, Meredith McKean, John Panagides, & Johannes Fürst. (1988). The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis. Clinical Pharmacology & Therapeutics. 43(5). 571–576. 24 indexed citations

12.

Garg, Dyal C., et al.. (1987). Comparative Pharmacodynamics and Pharmacokinetics of Conventional and Long‐Acting Propranolol. The Journal of Clinical Pharmacology. 27(5). 390–396. 8 indexed citations

13.

Cayen, Mitchell N., David Hicks, Eckhardt S. Ferdinandi, et al.. (1985). Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.. Drug Metabolism and Disposition. 13(4). 412–419. 14 indexed citations

14.

Cayen, Mitchell N., M. Kraml, Eckhardt S. Ferdinandi, E. Greselin, & D. Dvornik. (1981). The Metabolic Disposition of Etodolac in Rats, Dogs, and Man. Drug Metabolism Reviews. 12(2). 339–362. 49 indexed citations

15.

Dvornik, D., et al.. (1981). Comparative Bioavailability of Propranolol: Twice‐Daily Versus Four Times‐Daily Administration. The Journal of Clinical Pharmacology. 21(11). 472–476. 5 indexed citations

16.

Kraml, M., et al.. (1968). A semi-automated determination of serum triglycerides. Clinical Biochemistry. 2. 373–380. 34 indexed citations

17.

Kraml, M., J.-E. Dubuc, & D. Dvornik. (1967). Agents affecting lipid metabolism. XXVI. Specificity of some inhibitors of the late stages of cholesterol biosynthesis. Lipids. 2(1). 5–7. 7 indexed citations

18.

Zsoter, T, et al.. (1966). ADRENERGIC BETA RECEPTORS AND PLASMA FREE FATTY ACIDS. Journal of Pharmacology and Experimental Therapeutics. 152(3). 425–431. 19 indexed citations

19.

Dvornik, D., M. Kraml, & Jehan F. Bagli. (1964). Endogenous Formation of Δ^5,7,24-Cholestatrien-3βol. Journal of the American Chemical Society. 86(13). 2739–2741. 29 indexed citations

20.

Kraml, M. & L. P. Bouthillier. (1955). THE CONVERSION OF UROCANIC ACID TO GLUTAMIC ACID IN THE INTACT RAT. Canadian Journal of Biochemistry and Physiology. 33(1). 590–598. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact